E Provenzano, J L Hopper, G G Giles, G Marr, D J Venter, J E Armes. Eur J Cancer 2003
Times Cited: 89
Times Cited: 89
Times Cited
Times Co-cited
Similarity
Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics.
A Ringberg, L Anagnostaki, H Anderson, I Idvall, M Fernö. Eur J Cancer 2001
A Ringberg, L Anagnostaki, H Anderson, I Idvall, M Fernö. Eur J Cancer 2001
44
Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
38
The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
Dennis B Cornfield, Juan P Palazzo, Gordon F Schwartz, Shanth A Goonewardene, Albert J Kovatich, Inna Chervoneva, Terry Hyslop, Roland Schwarting. Cancer 2004
Dennis B Cornfield, Juan P Palazzo, Gordon F Schwartz, Shanth A Goonewardene, Albert J Kovatich, Inna Chervoneva, Terry Hyslop, Roland Schwarting. Cancer 2004
30
Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial.
Joan Houghton, W D George, Jack Cuzick, Catherine Duggan, Ian S Fentiman, Margaret Spittle. Lancet 2003
Joan Houghton, W D George, Jack Cuzick, Catherine Duggan, Ian S Fentiman, Margaret Spittle. Lancet 2003
22
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.
N Bijker, J L Peterse, L Duchateau, J P Julien, I S Fentiman, C Duval, S Di Palma, J Simony-Lafontaine, I de Mascarel, M J van de Vijver. J Clin Oncol 2001
N Bijker, J L Peterse, L Duchateau, J P Julien, I S Fentiman, C Duval, S Di Palma, J Simony-Lafontaine, I de Mascarel, M J van de Vijver. J Clin Oncol 2001
21
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.
B Fisher, J Dignam, N Wolmark, D L Wickerham, E R Fisher, E Mamounas, R Smith, M Begovic, N V Dimitrov, R G Margolese,[...]. Lancet 1999
B Fisher, J Dignam, N Wolmark, D L Wickerham, E R Fisher, E Mamounas, R Smith, M Begovic, N V Dimitrov, R G Margolese,[...]. Lancet 1999
21
The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast.
Melvin J Silverstein. Am J Surg 2003
Melvin J Silverstein. Am J Surg 2003
21
Prognostic classification of breast ductal carcinoma-in-situ.
M J Silverstein, D N Poller, J R Waisman, W J Colburn, A Barth, E D Gierson, B Lewinsky, P Gamagami, D J Slamon. Lancet 1995
M J Silverstein, D N Poller, J R Waisman, W J Colburn, A Barth, E D Gierson, B Lewinsky, P Gamagami, D J Slamon. Lancet 1995
20
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
20
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
Nina Bijker, Philip Meijnen, Johannes L Peterse, Jan Bogaerts, Irène Van Hoorebeeck, Jean-Pierre Julien, Massimiliano Gennaro, Philippe Rouanet, Antoine Avril, Ian S Fentiman,[...]. J Clin Oncol 2006
Nina Bijker, Philip Meijnen, Johannes L Peterse, Jan Bogaerts, Irène Van Hoorebeeck, Jean-Pierre Julien, Massimiliano Gennaro, Philippe Rouanet, Antoine Avril, Ian S Fentiman,[...]. J Clin Oncol 2006
19
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
19
Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Shi-Yi Wang, Tatyana Shamliyan, Beth A Virnig, Robert Kane. Breast Cancer Res Treat 2011
Shi-Yi Wang, Tatyana Shamliyan, Beth A Virnig, Robert Kane. Breast Cancer Res Treat 2011
19
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.
E R Fisher, J Dignam, E Tan-Chiu, J Costantino, B Fisher, S Paik, N Wolmark. Cancer 1999
E R Fisher, J Dignam, E Tan-Chiu, J Costantino, B Fisher, S Paik, N Wolmark. Cancer 1999
17
Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.
B Fisher, J Dignam, N Wolmark, E Mamounas, J Costantino, W Poller, E R Fisher, D L Wickerham, M Deutsch, R Margolese,[...]. J Clin Oncol 1998
B Fisher, J Dignam, N Wolmark, E Mamounas, J Costantino, W Poller, E R Fisher, D L Wickerham, M Deutsch, R Margolese,[...]. J Clin Oncol 1998
17
Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.
B Fisher, S Land, E Mamounas, J Dignam, E R Fisher, N Wolmark. Semin Oncol 2001
B Fisher, S Land, E Mamounas, J Dignam, E R Fisher, N Wolmark. Semin Oncol 2001
17
Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review.
Sara A Lari, Henry M Kuerer. J Cancer 2011
Sara A Lari, Henry M Kuerer. J Cancer 2011
17
Ductal carcinoma in situ, complexities and challenges.
Gregory D Leonard, Sandra M Swain. J Natl Cancer Inst 2004
Gregory D Leonard, Sandra M Swain. J Natl Cancer Inst 2004
16
Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
J P Julien, N Bijker, I S Fentiman, J L Peterse, V Delledonne, P Rouanet, A Avril, R Sylvester, F Mignolet, H Bartelink,[...]. Lancet 2000
J P Julien, N Bijker, I S Fentiman, J L Peterse, V Delledonne, P Rouanet, A Avril, R Sylvester, F Mignolet, H Bartelink,[...]. Lancet 2000
16
A prognostic index for ductal carcinoma in situ of the breast.
M J Silverstein, M D Lagios, P H Craig, J R Waisman, B S Lewinsky, W J Colburn, D N Poller. Cancer 1996
M J Silverstein, M D Lagios, P H Craig, J R Waisman, B S Lewinsky, W J Colburn, D N Poller. Cancer 1996
16
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
D Craig Allred, Stewart J Anderson, Soonmyung Paik, D Lawrence Wickerham, Iris D Nagtegaal, Sandra M Swain, Elefetherios P Mamounas, Thomas B Julian, Charles E Geyer, Joseph P Costantino,[...]. J Clin Oncol 2012
D Craig Allred, Stewart J Anderson, Soonmyung Paik, D Lawrence Wickerham, Iris D Nagtegaal, Sandra M Swain, Elefetherios P Mamounas, Thomas B Julian, Charles E Geyer, Joseph P Costantino,[...]. J Clin Oncol 2012
16
Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptors.
E B Claus, P Chu, C L Howe, T L Davison, D F Stern, D Carter, M P DiGiovanna. Exp Mol Pathol 2001
E B Claus, P Chu, C L Howe, T L Davison, D F Stern, D Carter, M P DiGiovanna. Exp Mol Pathol 2001
22
The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
E K Latta, S Tjan, R K Parkes, F P O'Malley. Mod Pathol 2002
E K Latta, S Tjan, R K Parkes, F P O'Malley. Mod Pathol 2002
15
High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS.
S Roka, M Rudas, S Taucher, P Dubsky, T Bachleitner-Hofmann, D Kandioler, M Gnant, R Jakesz. Eur J Surg Oncol 2004
S Roka, M Rudas, S Taucher, P Dubsky, T Bachleitner-Hofmann, D Kandioler, M Gnant, R Jakesz. Eur J Surg Oncol 2004
45
The influence of margin width on local control of ductal carcinoma in situ of the breast.
M J Silverstein, M D Lagios, S Groshen, J R Waisman, B S Lewinsky, S Martino, P Gamagami, W J Colburn. N Engl J Med 1999
M J Silverstein, M D Lagios, S Groshen, J R Waisman, B S Lewinsky, S Martino, P Gamagami, W J Colburn. N Engl J Med 1999
14
EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast.
Annette Lebeau, Angela Unholzer, Gudrun Amann, Michaela Kronawitter, Ingo Bauerfeind, Andrea Sendelhofert, Anette Iff, Udo Löhrs. Breast Cancer Res Treat 2003
Annette Lebeau, Angela Unholzer, Gudrun Amann, Michaela Kronawitter, Ingo Bauerfeind, Andrea Sendelhofert, Anette Iff, Udo Löhrs. Breast Cancer Res Treat 2003
20
Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
Karla Kerlikowske, Annette Molinaro, Imok Cha, Britt-Marie Ljung, Virginia L Ernster, Kim Stewart, Karen Chew, Dan H Moore, Fred Waldman. J Natl Cancer Inst 2003
Karla Kerlikowske, Annette Molinaro, Imok Cha, Britt-Marie Ljung, Virginia L Ernster, Kim Stewart, Karen Chew, Dan H Moore, Fred Waldman. J Natl Cancer Inst 2003
14
Identification of a basal-like subtype of breast ductal carcinoma in situ.
Chad A Livasy, Charles M Perou, Gamze Karaca, David W Cowan, Diane Maia, Susan Jackson, Chiu-Kit Tse, Sarah Nyante, Robert C Millikan. Hum Pathol 2007
Chad A Livasy, Charles M Perou, Gamze Karaca, David W Cowan, Diane Maia, Susan Jackson, Chiu-Kit Tse, Sarah Nyante, Robert C Millikan. Hum Pathol 2007
14
HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.
E Rakovitch, S Nofech-Mozes, W Hanna, S Narod, D Thiruchelvam, R Saskin, J Spayne, C Taylor, L Paszat. Br J Cancer 2012
E Rakovitch, S Nofech-Mozes, W Hanna, S Narod, D Thiruchelvam, R Saskin, J Spayne, C Taylor, L Paszat. Br J Cancer 2012
14
Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
J Boyages, G Delaney, R Taylor. Cancer 1999
J Boyages, G Delaney, R Taylor. Cancer 1999
13
Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.
A Ringberg, I Idvall, M Fernö, H Anderson, L Anagnostaki, P Boiesen, L Bondesson, E Holm, S Johansson, K Lindholm,[...]. Eur J Surg Oncol 2000
A Ringberg, I Idvall, M Fernö, H Anderson, L Anagnostaki, P Boiesen, L Bondesson, E Holm, S Johansson, K Lindholm,[...]. Eur J Surg Oncol 2000
25
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
13
Ductal carcinoma in situ: a proposal for a new classification.
R Holland, J L Peterse, R R Millis, V Eusebi, D Faverly, M J van de Vijver, B Zafrani. Semin Diagn Pathol 1994
R Holland, J L Peterse, R R Millis, V Eusebi, D Faverly, M J van de Vijver, B Zafrani. Semin Diagn Pathol 1994
12
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.
D C Allred, G M Clark, R Molina, A K Tandon, S J Schnitt, K W Gilchrist, C K Osborne, D C Tormey, W L McGuire. Hum Pathol 1992
D C Allred, G M Clark, R Molina, A K Tandon, S J Schnitt, K W Gilchrist, C K Osborne, D C Tormey, W L McGuire. Hum Pathol 1992
12
Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
H Buerger, F Otterbach, R Simon, C Poremba, R Diallo, T Decker, L Riethdorf, C Brinkschmidt, B Dockhorn-Dworniczak, W Boecker. J Pathol 1999
H Buerger, F Otterbach, R Simon, C Poremba, R Diallo, T Decker, L Riethdorf, C Brinkschmidt, B Dockhorn-Dworniczak, W Boecker. J Pathol 1999
12
SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening.
Stefan O Emdin, Bengt Granstrand, Anita Ringberg, Kerstin Sandelin, Lars-Gunnar Arnesson, Hans Nordgren, Harald Anderson, Hans Garmo, Lars Holmberg, Arne Wallgren. Acta Oncol 2006
Stefan O Emdin, Bengt Granstrand, Anita Ringberg, Kerstin Sandelin, Lars-Gunnar Arnesson, Hans Nordgren, Harald Anderson, Hans Garmo, Lars Holmberg, Arne Wallgren. Acta Oncol 2006
12
Detection of ductal carcinoma in situ in women undergoing screening mammography.
Virginia L Ernster, Rachel Ballard-Barbash, William E Barlow, Yingye Zheng, Donald L Weaver, Gary Cutter, Bonnie C Yankaskas, Robert Rosenberg, Patricia A Carney, Karla Kerlikowske,[...]. J Natl Cancer Inst 2002
Virginia L Ernster, Rachel Ballard-Barbash, William E Barlow, Yingye Zheng, Donald L Weaver, Gary Cutter, Bonnie C Yankaskas, Robert Rosenberg, Patricia A Carney, Karla Kerlikowske,[...]. J Natl Cancer Inst 2002
12
Effect of margins of excision on recurrence after local excision of ductal carcinoma in situ of the breast.
A G Douglas-Jones, J Logan, J M Morgan, R Johnson, R Williams. J Clin Pathol 2002
A G Douglas-Jones, J Logan, J M Morgan, R Johnson, R Williams. J Clin Pathol 2002
32
Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ.
N Bijker, J L Peterse, L Duchateau, E C Robanus-Maandag, C A Bosch, C Duval, S Pilotti, M J van de Vijver. Br J Cancer 2001
N Bijker, J L Peterse, L Duchateau, E C Robanus-Maandag, C A Bosch, C Duval, S Pilotti, M J van de Vijver. Br J Cancer 2001
14
Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program.
V L Ernster, J Barclay, K Kerlikowske, H Wilkie, R Ballard-Barbash. Arch Intern Med 2000
V L Ernster, J Barclay, K Kerlikowske, H Wilkie, R Ballard-Barbash. Arch Intern Med 2000
11
Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience.
Bruno Cutuli, Christine Cohen-Solal-le Nir, Brigitte de Lafontan, Hervé Mignotte, Virginie Fichet, Renaud Fay, Véronique Servent, Sylvia Giard, Claire Charra-Brunaud, Claire Lemanski,[...]. Int J Radiat Oncol Biol Phys 2002
Bruno Cutuli, Christine Cohen-Solal-le Nir, Brigitte de Lafontan, Hervé Mignotte, Virginie Fichet, Renaud Fay, Véronique Servent, Sylvia Giard, Claire Charra-Brunaud, Claire Lemanski,[...]. Int J Radiat Oncol Biol Phys 2002
11
The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
Melinda E Sanders, Peggy A Schuyler, William D Dupont, David L Page. Cancer 2005
Melinda E Sanders, Peggy A Schuyler, William D Dupont, David L Page. Cancer 2005
11
Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone.
W L Betsill, P P Rosen, P H Lieberman, G F Robbins. JAMA 1978
W L Betsill, P P Rosen, P H Lieberman, G F Robbins. JAMA 1978
11
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Salomone Di Saverio, Fausto Catena, Donatella Santini, Luca Ansaloni, Tommaso Fogacci, Stefano Mignani, Antonio Leone, Filippo Gazzotti, Stefano Gagliardi, Angelo De Cataldis,[...]. Breast Cancer Res Treat 2008
Salomone Di Saverio, Fausto Catena, Donatella Santini, Luca Ansaloni, Tommaso Fogacci, Stefano Mignani, Antonio Leone, Filippo Gazzotti, Stefano Gagliardi, Angelo De Cataldis,[...]. Breast Cancer Res Treat 2008
13
Classification of ductal carcinoma in situ by gene expression profiling.
Juliane Hannemann, Arno Velds, Johannes B G Halfwerk, Bas Kreike, Johannes L Peterse, Marc J van de Vijver. Breast Cancer Res 2006
Juliane Hannemann, Arno Velds, Johannes B G Halfwerk, Bas Kreike, Johannes L Peterse, Marc J van de Vijver. Breast Cancer Res 2006
11
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
11
p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.
Marnix A de Roos, Geertruida H de Bock, Jaap de Vries, Bert van der Vegt, Jelle Wesseling. J Surg Res 2007
Marnix A de Roos, Geertruida H de Bock, Jaap de Vries, Bert van der Vegt, Jelle Wesseling. J Surg Res 2007
32
Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Sevilay Altintas, Kathleen Lambein, Manon T Huizing, Geert Braems, Fernando Tjin Asjoe, Hilde Hellemans, Eric Van Marck, Joost Weyler, Marleen Praet, Rudy Van den Broecke,[...]. Breast J 2009
Sevilay Altintas, Kathleen Lambein, Manon T Huizing, Geert Braems, Fernando Tjin Asjoe, Hilde Hellemans, Eric Van Marck, Joost Weyler, Marleen Praet, Rudy Van den Broecke,[...]. Breast J 2009
30
Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010
11
Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.
S E Clark, J Warwick, R Carpenter, R L Bowen, S W Duffy, J L Jones. Br J Cancer 2011
S E Clark, J Warwick, R Carpenter, R L Bowen, S W Duffy, J L Jones. Br J Cancer 2011
11
Molecular phenotypes of DCIS predict overall and invasive recurrence.
K E Williams, N L P Barnes, A Cramer, R Johnson, K Cheema, J Morris, M Howe, N J Bundred. Ann Oncol 2015
K E Williams, N L P Barnes, A Cramer, R Johnson, K Cheema, J Morris, M Howe, N J Bundred. Ann Oncol 2015
14
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.